Covid-19 Archives

News and Trends 18 May 2023

Industry responds to UK science strategy launch

The UK Health Security Agency’s (UKHSA) has launched a 10-year science strategy, setting out how science can save more lives and contribute to the U.K.’s ambition of being a global science superpower. The strategy sets out how the UKHSA scientific capabilities – including genomics, vaccine evaluation, surveillance, data science, diagnostics and toxicology – will be […]

May 18, 2023 - 7 minutesmins - By Jim Cornall

News and Trends 26 Apr 2023

Global partners announce The Big Catch-up vaccination effort

WHO, UNICEF, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation, along with Immunization Agenda 2030 and many other global and national health partners, are joining forces to call for “The Big Catch-up,” a targeted global effort to boost vaccination among children following declines driven by the COVID-19 pandemic. Gavi, the Vaccine Alliance, […]

April 26, 2023 - 5 minutesmins - By Jim Cornall

Opinion 26 Apr 2023

Can mRNA vaccines tackle multiple diseases?

By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week to highlight the action needed and to promote the use of vaccines to protect people around the world, of all ages, against infectious diseases. World Immunization Week aims to promote the use of vaccines to […]

April 26, 2023 - 9 minutesmins - By External Contributor

Opinion 26 Apr 2023

How to address declining vaccination rates in older adults

By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last few years in light of the COVID-19 pandemic. New technologies have been applied at scale, innovative vaccine programs rolled out, and supply chains rearranged to help tackle global health challenges. But, while innovation has improved […]

April 26, 2023 - 5 minutesmins - By External Contributor

News and Trends 21 Apr 2023

Can artificial intelligence predict future pandemics?

Before the first cases of COVID-19 became known, an algorithm based on artificial intelligence developed by a company in Canada had already detected a new virus spreading across the Chinese city of Wuhan. This demonstration of the potential of new technologies applied to predicting future epidemics led a group of researchers at the Universitat Oberta […]

April 21, 2023 - 3 minutesmins - By Jim Cornall

In Depth 19 Apr 2023

How Vaccine Platforms Can Prepare Us for Future Pandemics

The COVID-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be powerful tools for reacting faster to future pandemics. Multiple COVID-19 vaccines became available across the world to tackle the COVID-19 pandemic, signaling a historic moment for vaccine development due to the speed at which they were created. And with scientists believing that […]

April 19, 2023 - 7 minutesmins - By Sachin Rawat

In Depth 14 Apr 2023

mRNA vaccines: a promising future

In 1978, nearly two decades after the discovery of messenger RNA (mRNA), the concept of a vaccine made from mRNA was materialized. Like its name suggests, mRNAs are messengers that aid in decoding genetic information from DNA to synthesize proteins, a key cellular function. Previous attempts at developing a vaccine using mRNA failed because mRNA […]

April 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 5 Apr 2023

InflaRx receives emergency use authorization for critically ill COVID-19 patients treatment

InflaRx N.V., a German company developing anti-inflammatory therapeutics by targeting the complement system, has announced that Gohibic (vilobelimab) has been granted an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalized adults. Vilobelimab is a first-in-class monoclonal anti-human complement factor C5a antibody that acts on […]

April 5, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 21 Mar 2023

Etana secures funding for oncology pipeline

PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. The round of financing will be used for further strengthening PT Etana Biotechnologies’ pipeline and portfolio especially in oncology. Currently, PT Etana Biotechnologies focuses on local biopharmaceutical production […]

March 21, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 20 Mar 2023

SpyBiotech receives more than $4 million to develop vaccine platform

UK-based SpyBiotech has received a grant of more than $4 million from the Bill & Melinda Gates Foundation to build its SpyVector platform for the development of a cross-protective coronavirus vaccine. The platform, which is based on recombinant adenovirus – a viral vector which can induce cellular immunity – enables a covalent decoration with the […]

March 20, 2023 - 2 minutesmins - By Roohi Mariam Peter

News and Trends 13 Mar 2023

New therapy for prevention and treatment of COVID-19

ExeVir Bio, and its scientific founders at Belgium’s VIB, Flanders’ leading life sciences institute, have published a pre-print paper by De Cae et al., entitled “Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane-proximal epitope of the spike.” Nearly all SARS-CoV-2 neutralizing antibodies used in the clinic show substantial loss of potency against the […]

March 13, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 14 Feb 2023

Scancell looking to partner after positive COVID vaccine data

Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease, has announced preliminary immunogenicity data from its phase 1 COVIDITY clinical trial at the University of Cape Town (UCT) Lung Institute in South Africa. The objectives of the trial were to assess the safety and immunogenicity of two vaccine candidates, […]

February 14, 2023 - 5 minutesmins - By Jim Cornall

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us